APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tafenoquine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tafenoquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026180 pages

Choose your research edition.

Industry ResearchTafenoquine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tafenoquine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Tafenoquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tafenoquine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tafenoquine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tafenoquine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tafenoquine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tafenoquine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tafenoquine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tafenoquine market size, projected growth trends, production technologies, key applications, and end-use industries.

Tafenoquine Segment by Company

Pharmacodia (Beijing) Co.,Ltd

Merck

GlaxoSmithKline Pharmaceuticals (GSK)

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.

J & K Scientific LTD

BOC Sciences

Amadis Chemical Company Limited

Tafenoquine Segment by Type

Powder

Pills

Tafenoquine Segment by Application

P. falciparum Treatment

Radical Cure of P.vivax

Prevention of Malaria Relapse

Tafenoquine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tafenoquine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tafenoquine Industry Trends Table 2. Tafenoquine Industry Drivers Table 3. Tafenoquine Industry Opportunities and Challenges Table 4. Tafenoquine Industry Restraints Table 5. Global Tafenoquine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tafenoquine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tafenoquine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tafenoquine Sales Market Share by Manufacturers Table 9. Global Tafenoquine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tafenoquine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tafenoquine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tafenoquine Manufacturers, Product Type & Application Table 13. Global Tafenoquine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tafenoquine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Pills Table 18. Global Tafenoquine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Tafenoquine Sales by Type (2021-2026) & (K Units) Table 20. Global Tafenoquine Sales by Type (2027-2032) & (K Units) Table 21. Global Tafenoquine Sales Market Share by Type (2021-2026) Table 22. Global Tafenoquine Sales Market Share by Type (2027-2032) Table 23. Global Tafenoquine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Tafenoquine Revenue by Type (2021-2026) & (K Units) Table 25. Global Tafenoquine Revenue by Type (2027-2032) & (K Units) Table 26. Global Tafenoquine Revenue Market Share by Type (2021-2026) Table 27. Global Tafenoquine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of P. falciparum Treatment Table 29. Major Manufacturers of Radical Cure of P.vivax Table 30. Major Manufacturers of Prevention of Malaria Relapse Table 31. Global Tafenoquine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Tafenoquine Sales by Application (2021-2026) & (K Units) Table 33. Global Tafenoquine Sales by Application (2027-2032) & (K Units) Table 34. Global Tafenoquine Sales Market Share by Application (2021-2026) Table 35. Global Tafenoquine Sales Market Share by Application (2027-2032) Table 36. Global Tafenoquine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Tafenoquine Revenue by Application (2021-2026) & (K Units) Table 38. Global Tafenoquine Revenue by Application (2027-2032) & (K Units) Table 39. Global Tafenoquine Revenue Market Share by Application (2021-2026) Table 40. Global Tafenoquine Revenue Market Share by Application (2027-2032) Table 41. Global Tafenoquine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Tafenoquine Sales by Region (2021-2026) & (K Units) Table 43. Global Tafenoquine Sales Market Share by Region (2021-2026) Table 44. Global Tafenoquine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Tafenoquine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Tafenoquine Sales by Country (2021-2026) & (K Units) Table 48. North America Tafenoquine Sales by Country (2027-2032) & (K Units) Table 49. Europe Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Tafenoquine Sales by Country (2021-2026) & (K Units) Table 51. Europe Tafenoquine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Tafenoquine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Tafenoquine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Tafenoquine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Tafenoquine Sales by Country (2027-2032) & (K Units) Table 58. Global Tafenoquine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tafenoquine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Tafenoquine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Tafenoquine Revenue Market Share by Region (2021-2026) Table 62. Global Tafenoquine Revenue Market Share by Region (2027-2032) Table 63. Pharmacodia (Beijing) Co.,Ltd Company Information Table 64. Pharmacodia (Beijing) Co.,Ltd Business Overview Table 65. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio Table 67. Pharmacodia (Beijing) Co.,Ltd Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Tafenoquine Product Portfolio Table 72. Merck Recent Development Table 73. GlaxoSmithKline Pharmaceuticals (GSK) Company Information Table 74. GlaxoSmithKline Pharmaceuticals (GSK) Business Overview Table 75. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio Table 77. GlaxoSmithKline Pharmaceuticals (GSK) Recent Development Table 78. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information Table 79. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview Table 80. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio Table 82. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Development Table 83. J & K Scientific LTD Company Information Table 84. J & K Scientific LTD Business Overview Table 85. J & K Scientific LTD Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. J & K Scientific LTD Tafenoquine Product Portfolio Table 87. J & K Scientific LTD Recent Development Table 88. BOC Sciences Company Information Table 89. BOC Sciences Business Overview Table 90. BOC Sciences Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. BOC Sciences Tafenoquine Product Portfolio Table 92. BOC Sciences Recent Development Table 93. Amadis Chemical Company Limited Company Information Table 94. Amadis Chemical Company Limited Business Overview Table 95. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Amadis Chemical Company Limited Tafenoquine Product Portfolio Table 97. Amadis Chemical Company Limited Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Tafenoquine Distributors List Table 101. Tafenoquine Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Tafenoquine Product Image Figure 2. Global Tafenoquine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tafenoquine Market Size (2021-2032) & (US$ Million) Figure 4. Global Tafenoquine Sales (2021-2032) & (K Units) Figure 5. Global Tafenoquine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tafenoquine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Pills Image Figure 10. Global Tafenoquine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Tafenoquine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tafenoquine Sales Market Share by Type (2021-2032) Figure 13. Global Tafenoquine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tafenoquine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tafenoquine Revenue Market Share by Type (2021-2032) Figure 16. P. falciparum Treatment Image Figure 17. Radical Cure of P.vivax Image Figure 18. Prevention of Malaria Relapse Image Figure 19. Global Tafenoquine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Tafenoquine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Tafenoquine Sales Market Share by Application (2021-2032) Figure 22. Global Tafenoquine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Tafenoquine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Tafenoquine Revenue Market Share by Application (2021-2032) Figure 25. North America Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Tafenoquine Sales Market Share by Country (2021-2032) Figure 27. U.S. Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Tafenoquine Sales Market Share by Country (2021-2032) Figure 32. Germany Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Tafenoquine Sales Market Share by Country (2021-2032) Figure 39. China Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Tafenoquine Sales Market Share by Country (2021-2032) Figure 47. Brazil Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Tafenoquine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Tafenoquine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Tafenoquine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Tafenoquine Revenue (2021-2032) & (US$ Million) Figure 58. North America Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Tafenoquine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Tafenoquine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Tafenoquine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Tafenoquine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Tafenoquine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Pills
Applications
  • P. falciparum Treatment
  • Radical Cure of P.vivax
  • Prevention of Malaria Relapse
Companies covered
  • Pharmacodia (Beijing) Co.,Ltd
  • Merck
  • GlaxoSmithKline Pharmaceuticals (GSK)
  • WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
  • J & K Scientific LTD
  • BOC Sciences
  • Amadis Chemical Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tafenoquine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tafenoquine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tafenoquine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tafenoquine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tafenoquine Market Dynamics
  1. 2.1 Tafenoquine Industry Trends
  2. 2.2 Tafenoquine Industry Drivers
  3. 2.3 Tafenoquine Industry Opportunities and Challenges
  4. 2.4 Tafenoquine Industry Restraints
3 Tafenoquine Market by Manufacturers
  1. 3.1 Global Tafenoquine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tafenoquine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tafenoquine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tafenoquine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tafenoquine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tafenoquine Manufacturers, Product Type & Application
  7. 3.7 Global Tafenoquine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tafenoquine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tafenoquine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tafenoquine Tier 1, Tier 2, and Tier 3
4 Tafenoquine Market by Type
  1. 4.1 Tafenoquine Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Pills
  4. 4.2 Global Tafenoquine Sales by Type
  5. 4.2.1 Global Tafenoquine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tafenoquine Sales by Type (2021-2032)
  7. 4.2.3 Global Tafenoquine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tafenoquine Revenue by Type
  9. 4.3.1 Global Tafenoquine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tafenoquine Revenue by Type (2021-2032)
  11. 4.3.3 Global Tafenoquine Revenue Market Share by Type (2021-2032)
5 Tafenoquine Market by Application
  1. 5.1 Tafenoquine Application Introduction
  2. 5.1.1 P. falciparum Treatment
  3. 5.1.2 Radical Cure of P.vivax
  4. 5.1.3 Prevention of Malaria Relapse
  5. 5.2 Global Tafenoquine Sales by Application
  6. 5.2.1 Global Tafenoquine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tafenoquine Sales by Application (2021-2032)
  8. 5.2.3 Global Tafenoquine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tafenoquine Revenue by Application
  10. 5.3.1 Global Tafenoquine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tafenoquine Revenue by Application (2021-2032)
  12. 5.3.3 Global Tafenoquine Revenue Market Share by Application (2021-2032)
6 Global Tafenoquine Sales by Region
  1. 6.1 Global Tafenoquine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tafenoquine Sales by Region (2021-2032)
  3. 6.2.1 Global Tafenoquine Sales by Region (2021-2026)
  4. 6.2.2 Global Tafenoquine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tafenoquine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tafenoquine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tafenoquine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tafenoquine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tafenoquine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tafenoquine Revenue by Region
  1. 7.1 Global Tafenoquine Revenue by Region
  2. 7.1.1 Global Tafenoquine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tafenoquine Revenue by Region (2021-2026)
  4. 7.1.3 Global Tafenoquine Revenue by Region (2027-2032)
  5. 7.1.4 Global Tafenoquine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tafenoquine Revenue (2021-2032)
  8. 7.2.2 North America Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tafenoquine Revenue (2021-2032)
  11. 7.3.2 Europe Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tafenoquine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tafenoquine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tafenoquine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pharmacodia (Beijing) Co.,Ltd
  2. 8.1.1 Pharmacodia (Beijing) Co.,Ltd Company Information
  3. 8.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
  4. 8.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
  6. 8.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Tafenoquine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GlaxoSmithKline Pharmaceuticals (GSK)
  14. 8.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
  15. 8.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
  16. 8.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
  18. 8.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
  19. 8.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
  20. 8.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
  21. 8.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
  22. 8.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
  24. 8.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
  25. 8.5 J & K Scientific LTD
  26. 8.5.1 J & K Scientific LTD Company Information
  27. 8.5.2 J & K Scientific LTD Business Overview
  28. 8.5.3 J & K Scientific LTD Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
  30. 8.5.5 J & K Scientific LTD Recent Developments
  31. 8.6 BOC Sciences
  32. 8.6.1 BOC Sciences Company Information
  33. 8.6.2 BOC Sciences Business Overview
  34. 8.6.3 BOC Sciences Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BOC Sciences Tafenoquine Product Portfolio
  36. 8.6.5 BOC Sciences Recent Developments
  37. 8.7 Amadis Chemical Company Limited
  38. 8.7.1 Amadis Chemical Company Limited Company Information
  39. 8.7.2 Amadis Chemical Company Limited Business Overview
  40. 8.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
  42. 8.7.5 Amadis Chemical Company Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tafenoquine Value Chain Analysis
  2. 9.1.1 Tafenoquine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tafenoquine Production Mode & Process
  6. 9.2 Tafenoquine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tafenoquine Distributors
  9. 9.2.3 Tafenoquine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst